Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Peptide; galanin antagonist.
Coumarin glucoside found in Aesculus, Daphne, a...
AR antagonist.
p110α PI3K and mTOR inhibitor.
Diazabicyclooctane β-lactamase inhibitor.
Antioxidant.
Peptide, involved in neutrophil activation; FPR...
Mycotoxin contaminant found in cereal grains.
Polyether Ca2+ ionophore.
Cysteine-ITC conjugate, antioxidant; aldehyde d...
Protein translation inhibitor.
Calcitonin-family peptide, involved in vasodila...
Lincosamide; ribosomal translocation and protei...
Peptide fragment of VSV; LDLR agonist.
Allosteric inhibitor
JAK1/2 inhibitor.
Notch inhibitor.
Amide form of vitamin B3 required for productio...
Polyether pyrrole, divalent cation ionophore.
Cationic antimicrobial peptide, alters bacteria...